Published in Semin Immunopathol on July 21, 2012
Mycoplasma pneumoniae infection in children is a risk factor for developing allergic diseases. ScientificWorldJournal (2014) 0.95
Elevated antigen-driven IL-9 responses are prominent in peanut allergic humans. PLoS One (2012) 0.84
Food allergy diagnosis and therapy: where are we now? Immunotherapy (2013) 0.79
Current Options for the Treatment of Food Allergy. Pediatr Clin North Am (2015) 0.77
The Potential of Anti-IgE in Food Allergy Therapy. Curr Treat Options Allergy (2014) 0.76
Exposure to SIV in utero results in reduced viral loads and altered responsiveness to postnatal challenge. Sci Transl Med (2015) 0.76
Role of Regulatory Cells in Oral Tolerance. Allergy Asthma Immunol Res (2017) 0.75
The efficacy of oral and subcutaneous antigen-specific immunotherapy in murine cow's milk- and peanut allergy models. Clin Transl Allergy (2017) 0.75
Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med (2003) 26.05
Induction of colonic regulatory T cells by indigenous Clostridium species. Science (2010) 16.71
Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol (2011) 6.23
Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol (2001) 5.80
JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest (2000) 5.12
Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature (2012) 4.33
Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol (2007) 4.25
Specific oral tolerance induction in children with very severe cow's milk-induced reactions. J Allergy Clin Immunol (2007) 4.16
Food allergy. J Allergy Clin Immunol (2009) 4.05
Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol (2009) 3.91
Oral tolerance in the absence of naturally occurring Tregs. J Clin Invest (2005) 3.73
Oral tolerance. Immunol Rev (2005) 3.48
Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent. J Exp Med (2005) 3.48
Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity (2003) 3.28
Thymic stromal lymphopoietin: master switch for allergic inflammation. J Exp Med (2006) 3.25
A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy. J Allergy Clin Immunol (2008) 3.19
The natural history of IgE-mediated cow's milk allergy. J Allergy Clin Immunol (2007) 3.08
Prevalence of peanut and tree nut allergy in the United States determined by means of a random digit dial telephone survey: a 5-year follow-up study. J Allergy Clin Immunol (2003) 3.06
IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol (2010) 3.04
Egg oral immunotherapy in nonanaphylactic children with egg allergy. J Allergy Clin Immunol (2006) 3.03
Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J Immunol (1997) 2.91
Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol (2006) 2.80
IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J Allergy Clin Immunol (2009) 2.77
The impact of childhood food allergy on quality of life. Ann Allergy Asthma Immunol (2001) 2.77
A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol (2011) 2.77
IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol (2003) 2.62
Oral peanut immunotherapy in children with peanut anaphylaxis. J Allergy Clin Immunol (2010) 2.50
Commensal bacteria-derived signals regulate basophil hematopoiesis and allergic inflammation. Nat Med (2012) 2.49
TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation. Nature (2011) 2.42
Specific oral tolerance induction in food allergy in children: efficacy and clinical patterns of reaction. Allergy (2007) 2.41
Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity. J Immunol (2004) 2.40
Food allergy among U.S. children: trends in prevalence and hospitalizations. NCHS Data Brief (2008) 2.39
A protocol for oral desensitization in children with IgE-mediated cow's milk allergy. Allergy (2004) 2.39
Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol (1997) 2.35
Structure and function of immunoglobulins. J Allergy Clin Immunol (2010) 2.22
The psychosocial impact of food allergy and food hypersensitivity in children, adolescents and their families: a review. Allergy (2010) 2.20
Retracted The cytokine interleukin-33 mediates anaphylactic shock. Proc Natl Acad Sci U S A (2009) 2.15
Future therapies for food allergies. J Allergy Clin Immunol (2011) 2.04
Rising prevalence of allergy to peanut in children: Data from 2 sequential cohorts. J Allergy Clin Immunol (2002) 2.02
Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract. J Allergy Clin Immunol (2005) 1.99
CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity (2008) 1.95
Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the FcepsilonRI. Proc Natl Acad Sci U S A (2003) 1.94
Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol (2003) 1.94
The natural history of peanut allergy in young children and its association with serum peanut-specific IgE. J Pediatr (2000) 1.93
Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization. J Allergy Clin Immunol (2011) 1.93
In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J Exp Med (2008) 1.91
The natural history of peanut allergy. J Allergy Clin Immunol (2001) 1.89
Successful oral tolerance induction in severe peanut allergy. Allergy (2009) 1.86
Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol (2011) 1.84
Role of Treg in immune regulation of allergic diseases. Eur J Immunol (2010) 1.82
The safety and efficacy of sublingual and oral immunotherapy for milk allergy. J Allergy Clin Immunol (2011) 1.81
Phl p 5 resorption in human oral mucosa leads to dose-dependent and time-dependent allergen binding by oral mucosal Langerhans cells, attenuates their maturation, and enhances their migratory and TGF-beta1 and IL-10-producing properties. J Allergy Clin Immunol (2010) 1.80
Allergic dysregulation and hyperimmunoglobulinemia E in Foxp3 mutant mice. J Allergy Clin Immunol (2005) 1.75
Allergen-specific immunotherapy with recombinant grass pollen allergens. J Allergy Clin Immunol (2005) 1.68
Association of allergen-specific regulatory T cells with the onset of clinical tolerance to milk protein. J Allergy Clin Immunol (2009) 1.66
Rapid oral desensitization in combination with omalizumab therapy in patients with cow's milk allergy. J Allergy Clin Immunol (2011) 1.57
Adverse reactions during peanut oral immunotherapy home dosing. J Allergy Clin Immunol (2009) 1.53
CD4+CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling. J Allergy Clin Immunol (2008) 1.51
Characterization of lymphocyte responses to peanuts in normal children, peanut-allergic children, and allergic children who acquired tolerance to peanuts. J Clin Invest (2003) 1.48
Mechanisms of immunotherapy. J Allergy Clin Immunol (2004) 1.45
Grass pollen immunotherapy induces Foxp3-expressing CD4+ CD25+ cells in the nasal mucosa. J Allergy Clin Immunol (2008) 1.43
Specificity of IgE antibodies to sequential epitopes of hen's egg ovomucoid as a marker for persistence of egg allergy. Allergy (2007) 1.41
T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases. J Allergy Clin Immunol (2005) 1.38
Update on risk factors for food allergy. J Allergy Clin Immunol (2012) 1.33
B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. J Immunol (1994) 1.33
Influence of bee venom immunotherapy on degranulation and leukotriene generation in human blood basophils. Clin Exp Allergy (1996) 1.32
Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll-like receptors. Allergy (2008) 1.27
Mechanisms of immunotherapy: IgG revisited. Curr Opin Allergy Clin Immunol (2004) 1.26
The US Peanut and Tree Nut Allergy Registry: characteristics of reactions in schools and day care. J Pediatr (2001) 1.21
Toll-like receptor 4 ligation enforces tolerogenic properties of oral mucosal Langerhans cells. J Allergy Clin Immunol (2007) 1.21
Peanut and tree nut allergic reactions in restaurants and other food establishments. J Allergy Clin Immunol (2001) 1.19
Changes in antigen-specific T-cell number and function during oral desensitization in cow's milk allergy enabled with omalizumab. Mucosal Immunol (2012) 1.18
Randomized double-blind, placebo-controlled trial of sublingual immunotherapy with a Pru p 3 quantified peach extract. Allergy (2009) 1.18
Cow's milk epicutaneous immunotherapy in children: a pilot trial of safety, acceptability, and impact on allergic reactivity. J Allergy Clin Immunol (2010) 1.17
Severe anaphylaxis to kiwi fruit: Immunologic changes related to successful sublingual allergen immunotherapy. J Allergy Clin Immunol (2003) 1.17
Specific oral tolerance induction with food in children: transient or persistent effect on food allergy? Allergy (2005) 1.16
Characterization of dendritic cells from human oral mucosa: a new Langerhans' cell type with high constitutive FcepsilonRI expression. J Allergy Clin Immunol (2003) 1.16
Inducible CD4+LAP+Foxp3- regulatory T cells suppress allergic inflammation. J Immunol (2011) 1.16
Oral tolerance, an active immunologic process mediated by multiple mechanisms. J Clin Invest (2000) 1.14
Effect of immunotherapy on immunoglobulin E and immunoglobulin G antibodies to ragweed antigens: a six-year prospective study. J Allergy Clin Immunol (1982) 1.13
Increased serum thymic stromal lymphopoietin in children with atopic dermatitis. Pediatr Allergy Immunol (2010) 1.12
Mechanisms of allergen-specific desensitization. J Allergy Clin Immunol (2010) 1.11
Human Peyer's patch T cells are sensitized to dietary antigen and display a Th cell type 1 cytokine profile. J Immunol (2000) 1.11
Interleukin (IL)-10 inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells. J Clin Invest (1996) 1.10
Clinical relevance of the venom-specific immunoglobulin G antibody level during immunotherapy. J Allergy Clin Immunol (1982) 1.10
Rush oral immunotherapy in children with persistent cow's milk allergy. J Allergy Clin Immunol (2008) 1.10
IL-10 inhibits CD28 and ICOS costimulations of T cells via src homology 2 domain-containing protein tyrosine phosphatase 1. J Allergy Clin Immunol (2007) 1.08
Accidental allergic reactions in children allergic to cow's milk proteins. J Allergy Clin Immunol (2009) 1.07
Immunological and clinical changes in allergic asthmatics following treatment with omalizumab. Int Arch Allergy Immunol (2003) 1.06
Mechanisms of allergen-specific immunotherapy. Clin Transl Allergy (2012) 1.06
Individualized IgE-based dosing of egg oral immunotherapy and the development of tolerance. Ann Allergy Asthma Immunol (2010) 1.05
Allergen-specific nasal IgG antibodies induced by vaccination with genetically modified allergens are associated with reduced nasal allergen sensitivity. J Allergy Clin Immunol (2005) 1.04
Life-threatening anaphylaxis to kiwi fruit: protective sublingual allergen immunotherapy effect persists even after discontinuation. J Allergy Clin Immunol (2006) 1.03
T cell epitope specificity in human allergic and nonallergic subjects to bee venom phospholipase A2. J Immunol (1993) 1.00
Tracking antigen-specific T-cells during clinical tolerance induction in humans. PLoS One (2010) 0.99
Rush specific oral tolerance induction in school-age children with severe egg allergy: one year follow up. Allergol Int (2010) 0.99
Oral desensitization in children with immunoglobulin E-mediated cow's milk allergy--follow-up at 4 yr and 8 months. Pediatr Allergy Immunol (2008) 0.99
Innate Th2-type immune responses and the natural helper cell, a newly identified lymphocyte population. Curr Opin Allergy Clin Immunol (2011) 0.96
Measurement of IgE antibodies against purified grass pollen allergens (Lol p 1, 2, 3 and 5) during immunotherapy. Clin Exp Allergy (1997) 0.96
Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med (2003) 6.42
Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol (2011) 6.23
CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N Engl J Med (2006) 5.89
TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity (2007) 4.49
Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature (2012) 4.33
Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med (2002) 3.80
Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17. J Exp Med (2008) 3.19
TIM-4 is the ligand for TIM-1, and the TIM-1-TIM-4 interaction regulates T cell proliferation. Nat Immunol (2005) 3.00
Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease. Blood (2009) 2.91
The TIM gene family: emerging roles in immunity and disease. Nat Rev Immunol (2003) 2.90
TIM-1 induces T cell activation and inhibits the development of peripheral tolerance. Nat Immunol (2005) 2.77
The many paths to asthma: phenotype shaped by innate and adaptive immunity. Nat Immunol (2010) 2.74
TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity. Immunol Rev (2010) 2.64
Natural killer T cells in the lungs of patients with asthma. J Allergy Clin Immunol (2009) 2.57
Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity. Nat Immunol (2004) 2.43
Glycolipid activation of invariant T cell receptor+ NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4+ T cells. Proc Natl Acad Sci U S A (2006) 2.34
Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity. J Allergy Clin Immunol (2011) 2.12
The costimulatory role of TIM molecules. Immunol Rev (2009) 2.07
Differential engagement of Tim-1 during activation can positively or negatively costimulate T cell expansion and effector function. J Exp Med (2007) 1.93
Immunology: hepatitis A virus link to atopic disease. Nature (2003) 1.88
A polymorphism in TIM1 is associated with susceptibility to severe hepatitis A virus infection in humans. J Clin Invest (2011) 1.79
T cell/transmembrane, Ig, and mucin-3 allelic variants differentially recognize phosphatidylserine and mediate phagocytosis of apoptotic cells. J Immunol (2010) 1.79
TIM-1 and TIM-3 enhancement of Th2 cytokine production by mast cells. Blood (2007) 1.74
TIM-1, a novel allergy and asthma susceptibility gene. Springer Semin Immunopathol (2003) 1.72
Immunostimulatory Tim-1-specific antibody deprograms Tregs and prevents transplant tolerance in mice. J Clin Invest (2008) 1.66
Influenza infection in suckling mice expands an NKT cell subset that protects against airway hyperreactivity. J Clin Invest (2010) 1.60
Rapid oral desensitization in combination with omalizumab therapy in patients with cow's milk allergy. J Allergy Clin Immunol (2011) 1.57
TIM family of genes in immunity and tolerance. Adv Immunol (2006) 1.56
CD4 T-helper cells engineered to produce IL-10 prevent allergen-induced airway hyperreactivity and inflammation. J Allergy Clin Immunol (2002) 1.56
T cells and NKT cells in the pathogenesis of asthma. Annu Rev Med (2008) 1.54
TIM-family proteins promote infection of multiple enveloped viruses through virion-associated phosphatidylserine. PLoS Pathog (2013) 1.53
Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individuals. Ann Allergy Asthma Immunol (2004) 1.40
Role of regulatory T cells in allergy and asthma. Curr Opin Immunol (2003) 1.33
PDE4D plays a critical role in the control of airway smooth muscle contraction. FASEB J (2003) 1.22
Exaggerated IL-17 response to epicutaneous sensitization mediates airway inflammation in the absence of IL-4 and IL-13. J Allergy Clin Immunol (2009) 1.22
ICOS/ICOSL interaction is required for CD4+ invariant NKT cell function and homeostatic survival. J Immunol (2008) 1.14
iNKT cells require CCR4 to localize to the airways and to induce airway hyperreactivity. J Immunol (2007) 1.13
Direct activation of natural killer T cells induces airway hyperreactivity in nonhuman primates. J Allergy Clin Immunol (2008) 1.12
A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients. J Allergy Clin Immunol (2013) 1.11
TIM-4, a receptor for phosphatidylserine, controls adaptive immunity by regulating the removal of antigen-specific T cells. J Immunol (2010) 1.10
RGMb is a novel binding partner for PD-L2 and its engagement with PD-L2 promotes respiratory tolerance. J Exp Med (2014) 1.09
Tim-1 stimulation of dendritic cells regulates the balance between effector and regulatory T cells. Eur J Immunol (2011) 1.08
Pulmonary inflammation induced by subacute ozone is augmented in adiponectin-deficient mice: role of IL-17A. J Immunol (2012) 1.08
Apoptotic cells activate NKT cells through T cell Ig-like mucin-like-1 resulting in airway hyperreactivity. J Immunol (2010) 1.08
Targeted deletion of tumor suppressor PTEN augments neutrophil function and enhances host defense in neutropenia-associated pneumonia. Blood (2009) 1.06
Critical role of B cells in the development of T cell tolerance to aeroallergens. Int Immunol (2002) 1.06
Critical role of CD81 in cognate T-B cell interactions leading to Th2 responses. Int Immunol (2002) 1.05
Invariant natural killer T cells recognize a fungal glycosphingolipid that can induce airway hyperreactivity. Nat Med (2013) 1.03
Animal models of airway sensitization. Curr Protoc Immunol (2007) 1.02
Lack of iNKT cells in patients with combined immune deficiency due to hypomorphic RAG mutations. Blood (2007) 1.02
Agreement among measures of asthma status: a prospective study of low-income children with moderate to severe asthma. Pediatrics (2002) 1.00
Immunoglobulin A (IgA) is a natural ligand of hepatitis A virus cellular receptor 1 (HAVCR1), and the association of IgA with HAVCR1 enhances virus-receptor interactions. J Virol (2007) 1.00
Oral immunotherapy for food allergy: towards a new horizon. Allergy Asthma Immunol Res (2012) 0.98
Effectiveness of a multicomponent self-management program in at-risk, school-aged children with asthma. Ann Allergy Asthma Immunol (2004) 0.98
Innate immunity in the lung regulates the development of asthma. Immunol Rev (2014) 0.97
Allergen-specific MHC class II tetramer+ cells are detectable in allergic, but not in nonallergic, individuals. J Immunol (2006) 0.97
The development of airway hyperreactivity in T-bet-deficient mice requires CD1d-restricted NKT cells. J Immunol (2009) 0.96
Report of a case of immunosuppression with prednisone in an 8-year-old boy with an acute onset of hypocretin-deficiency narcolepsy. Sleep (2003) 0.96
Tim-1 signaling substitutes for conventional signal 1 and requires costimulation to induce T cell proliferation. J Immunol (2009) 0.96
Oral immunotherapy and anti-IgE antibody-adjunctive treatment for food allergy. Immunol Allergy Clin North Am (2012) 0.95
Flu strikes the hygiene hypothesis. Nat Med (2004) 0.95
Decreases in circulating CD4+CD25hiFOXP3+ cells and increases in intragraft FOXP3+ cells accompany allograft rejection in pediatric liver allograft recipients. Pediatr Transplant (2008) 0.95
In vivo regulation of the allergic response by the IL-4 receptor alpha chain immunoreceptor tyrosine-based inhibitory motif. J Allergy Clin Immunol (2010) 0.94
CD8(+) T cells regulate immune responses in a murine model of allergen-induced sensitization and airway inflammation. Eur J Immunol (2004) 0.92
Immunologic effects of omalizumab in children with severe refractory atopic dermatitis: a randomized, placebo-controlled clinical trial. Int Arch Allergy Immunol (2013) 0.89
Binding of hepatitis A virus to its cellular receptor 1 inhibits T-regulatory cell functions in humans. Gastroenterology (2012) 0.89
Respiratory tolerance in the protection against asthma. Curr Drug Targets Inflamm Allergy (2003) 0.88
Inhibition of the allergic response by regulatory T cells. Curr Opin Allergy Clin Immunol (2006) 0.88
Pivotal role of IL-6 in the hyperinflammatory responses to subacute ozone in adiponectin-deficient mice. Am J Physiol Lung Cell Mol Physiol (2013) 0.86
Respiratory tolerance is inhibited by the administration of corticosteroids. J Immunol (2005) 0.86
Vaccine-induced antibody isotypes are skewed by impaired CD4 T cell and invariant NKT cell effector responses in MyD88-deficient mice. J Immunol (2009) 0.85
CD1d restricted natural killer T cells are not required for allergic skin inflammation. J Allergy Clin Immunol (2006) 0.84
Mucosal tolerance and immunity: regulating the development of allergic disease and asthma. Int Arch Allergy Immunol (2003) 0.84
T-cell immunoglobulin and mucin domain 1 deficiency eliminates airway hyperreactivity triggered by the recognition of airway cell death. J Allergy Clin Immunol (2013) 0.83
Role of regulatory dendritic cells in allergy and asthma. Curr Opin Allergy Clin Immunol (2004) 0.81
Role of regulatory dendritic cells in allergy and asthma. Curr Allergy Asthma Rep (2005) 0.81
Synthesis of fungal glycolipid asperamide B and investigation of its ability to stimulate natural killer T cells. Org Lett (2013) 0.80
The role of type 2 innate lymphoid cells in asthma. J Leukoc Biol (2013) 0.80
TNF receptor-associated factor 1 expressed in resident lung cells is required for the development of allergic lung inflammation. J Immunol (2008) 0.80
Intronic SH2D1A mutation with impaired SAP expression and agammaglobulinemia. Clin Immunol (2012) 0.77
Genotype, phenotype, and outcomes of nine patients with T-B+NK+ SCID. Pediatr Transplant (2011) 0.77
Invariant natural killer T cells in obstructive pulmonary diseases. N Engl J Med (2007) 0.75
Sublingual desensitization for buprenorphine hypersensitivity. J Allergy Clin Immunol (2010) 0.75
Mechanisms by which obesity impacts asthma. Thorax (2016) 0.75
Editorial overview: novel concepts in the pathogenesis and therapy of allergy and asthma. Springer Semin Immunopathol (2003) 0.75
Natural killer T cells regulate the development of asthma. Expert Rev Clin Immunol (2009) 0.75